Flexible Flat-Rate Plans
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
DrugPatentWatch Database Preview
Arbor Pharms Llc Company Profile
« Back to Dashboard
Summary for Applicant: Arbor Pharms Llc
| Patents: | 16 |
| Tradenames: | 21 |
| Ingredients: | 13 |
| NDAs: | 20 |
| Drug Master File Entries: | 0 |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Arbor Pharms Llc | SKLICE | ivermectin | LOTION;TOPICAL | 202736-001 | Feb 7, 2012 | RX | Yes | 8,927,595 | Oct 12, 2027 | ||||||||||||||||||||
Arbor Pharms Llc | E.E.S. 400 | erythromycin ethylsuccinate | SUSPENSION;ORAL | 061639-002 | Approved Prior to Jan 1, 1982 | DISCN | No | ||||||||||||||||||||||
Arbor Pharms Llc | ERY-TAB | erythromycin | TABLET, DELAYED RELEASE;ORAL | 062298-001 | Approved Prior to Jan 1, 1982 | RX | No | ||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Similar Applicant Names
Here is a list of applicants with similar names.
« Back to Dashboard
For more information try a trial or see the database preview and plans and pricing
How are People Using DrugPatentWatch?
To identify Paragraph IV challenge opportunities and for product portfolio development
— Business development, China
For information on medications and their innovator companies, as well as their patency profiles
— Pharmacist, Nigeria
Patent information on sterle manufactured drugs and when they expire
— Regulatory affairs for a drug compounder, USA
For information on drug expiration / generic availability
— Pharmacist, USA
For knowledge about patent expiration dates and ongoing patent challenges
— Generic pharma, Canada
For paragraph IV challenge research
— Pharmaceutical company, USA
To get information about drug synthesis
— Chemical research, Spain
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639
